Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.1500 (6.32%) ($13.3500 - $15.2500) on Fri. Nov. 4, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 39 | Latest Price | $15.1500(6.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -2.005% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-9%) IPO(-5%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0 () | Intraday Trend | 10.2% | | | |
|
5 Day Moving Average | $13.97(8.45%) | 10 Day Moving Average | $13.97(8.45%) | 20 Day Moving Average | $14.99(1.07%) | To recent high | -39.1% | To recent low | 18.4% | Market Cap | $1.126b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |